Article
Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases
4 Mar 2015
Abstract excerpt
The text describes a preventive clinical trial with drug treatment in a very rare neurodegenerative disease (Fatal familial Insomnia, FFI) designed with the help of individuals at genetic risk of developing the disease, asymptomatic carriers, who have agreed to be exposed over a 10-year period to doxycycline, an antibiotic with anti-prion activity. At least 10 carriers of the FFI mutation over 42 y old will be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
